Cosmos Health Inc.
NASDAQ Capital MarketTotal Valuation
Cosmos Health Inc. carries a market capitalization of 13.43M, placing it among publicly traded companies globally. Its enterprise value stands at 28.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.43M |
| Enterprise Value | 28.13M |
Share Statistics
Cosmos Health Inc. currently has 50.82M shares outstanding.
| Shares Outstanding | 50.82M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.16, and the price-to-book ratio stands at -0.08.
| PE Ratio | N/A |
| PS Ratio | 0.16 |
| PB Ratio | -0.08 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | -1.23 |
| P/OCF Ratio | -1.21 |
Enterprise Valuation
| EV / Sales | 0.40 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Cosmos Health Inc. maintains a current ratio of 1.08, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 87.87, indicating elevated leverage, while an interest coverage ratio of -5.08 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.08 |
| Quick Ratio | 0.63 |
| Debt / Equity | 87.87 |
| Debt / EBITDA | -1.06 |
| Interest Coverage | -5.08 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -35.35 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.99 |
Stock Price Statistics
Cosmos Health Inc.'s stock has declined approximately -46.13537% over the past 52 weeks. The 50-day moving average sits at 0.32, while the 200-day moving average is 0.58.
| Beta (5Y) | N/A |
| 52-Week Price Change | -46.13537% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.58 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Cosmos Health Inc. generated 69.49M in revenue and converted that into -21.13M in net income, yielding earnings per share of -0.60. EBITDA reached -16.49M, while operating income came in at -17.89M.
| Revenue | 69.49M |
| Gross Profit | 7.23M |
| Operating Income | -17.89M |
| Pretax Income | -21.13M |
| Net Income | -21.13M |
| EBITDA | -16.49M |
| EBIT | -17.89M |
| Earnings Per Share (EPS) | -0.60 |
Balance Sheet
Cosmos Health Inc. holds 548,927.00 in cash and equivalents against 17.42M in total debt, resulting in a net debt position of 16.24M. Total book value stands at -135.92M, with working capital of 2.81M providing operational flexibility.
| Cash & Cash Equivalents | 548,927.00 |
| Total Debt | 17.42M |
| Net Debt | 16.24M |
| Equity (Book Value) | -135.92M |
| Book Value Per Share | -3.83 |
| Working Capital | 2.81M |
Cash Flow
Cosmos Health Inc. produced -9.33M in operating cash flow over the past twelve months. After subtracting -150,414.00 in capital expenditures, free cash flow totaled -9.48M - equivalent to -0.27 per share.
| Operating Cash Flow | -9.33M |
| Capital Expenditures | -150,414.00 |
| Free Cash Flow | -9.48M |
| FCF Per Share | -0.27 |
Margins
Cosmos Health Inc. operates with a gross margin of 10.40, reflecting its pricing power and cost economics. The operating margin of -25.75 and net profit margin of -30.41 provide insight into operational efficiency.
| Gross Margin | 10.40 |
| Operating Margin | -25.75 |
| Pretax Margin | -30.41 |
| Profit Margin | -30.41 |
| EBITDA Margin | -23.74 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -122.97 |
| FCF Yield | -81.53 |
Stock Splits
Cosmos Health Inc.'s most recent stock split took place on December 16, 2022 with a 25:1 split ratio.
| Last Split Date | 12/16/2022 |
| Split Ratio | 25:1 |
Scores
Cosmos Health Inc. posts an Altman Z-Score of -3.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.04 |